The combination of chemotherapy, immunotherapy, and CT guided percutaneous microwave ablation has finally brought dawn to advanced lung cancer patients!

Recently, Director Fan Jianyong of the Respiratory Department led a team to perform chemotherapy combined with immunotherapy and CT guided percutaneous microwave ablation for an elderly patient with advanced lung cancer, greatly improving their quality of life.

I thought my life was coming to an end, but after treatment, I feel better and better now. I have no problems with my daily life! "On that day, Mr. Wang came to the hospital for a check-up. As usual, he came to Director Fan Jianyong's office to chat about the latest situation. Now, "advanced lung cancer" is no longer a word that scares him.

Two years ago, Mr. Wang, 72 years old, found multiple thick walled hollow nodules in the upper lobes of both lungs during an external examination. The diameter of the left upper lobe was about 25mm. In order to clarify the diagnosis, Mr. Wang underwent CT guided lung biopsy, which revealed multiple primary lung adenocarcinoma and secondary malignant tumors in both lungs.

Data shows that lung cancer, as the "number one killer" of malignant tumors with the highest incidence rate and mortality in China, has an increasing incidence rate year by year. In clinical practice, about 80% of people in China have found that lung cancer is already in advanced stage, and 80% of them can hardly survive for more than one year.

The sudden bad news caught Mr. Wang's family off guard. In order to receive better treatment, Mr. Wang came to Xi'an International Medical Center Hospital for treatment.

After admission, Director Fan Jianyong comprehensively evaluated Mr. Wang's condition and developed a personalized treatment plan based on the actual situation.

After receiving chemotherapy combined with immunotherapy at the doctor's suggestion, it's really reassuring to be hospitalized here! "After treatment, Mr. Wang's bilateral lung lesions were significantly reduced, which showed him hope for life.

In order to further eliminate the lesion, Director Fan Jianyong conducted CT guided percutaneous microwave ablation for Mr. Wang. Later, CT examination showed that the lesions in both lungs had shrunk again.

Now, Mr. Wang has returned to a normal life.

Lung cancer is one of the most common and fatal diseases in the world today, with the highest number of deaths. Its main clinical manifestations include coughing, expectoration, hemoptysis, chest tightness, chest pain, and difficulty breathing. People with these symptoms must pay attention to lung cancer screening. Director Fan Jianyong suggests that high-risk individuals who have been smoking for a long time, have a family history of lung cancer, and work in closed environments or environments with high dust particles for a long time, CT examination should be performed once a year.

For a long time, under the leadership of Dean Wu Changgui, the Department of Respiratory and Critical Care Medicine has provided comprehensive interventional diagnosis and treatment services for patients with pulmonary nodules, lung cancer, asthma, chronic obstructive pulmonary disease, and difficult interstitial lung disease, providing the best personalized diagnosis and treatment plan for the majority of patients, and maximizing patient survival.